Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-24-034312
Filing Date
2024-08-29
Accepted
2024-08-29 09:58:39
Documents
19

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 304210
2 ex5-1.htm EX-5.1 14012
3 ex23-1.htm EX-23.1 3681
4 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 21257
5 ex5-1_001.jpg GRAPHIC 41157
6 ex5-1_002.jpg GRAPHIC 85560
  Complete submission text file 0001493152-24-034312.txt   779047

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE imnn-20240630.xsd EX-101.SCH 3254
8 XBRL DEFINITION FILE imnn-20240630_def.xml EX-101.DEF 30343
9 XBRL LABEL FILE imnn-20240630_lab.xml EX-101.LAB 37018
10 XBRL PRESENTATION FILE imnn-20240630_pre.xml EX-101.PRE 27394
21 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 5071
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-281834 | Film No.: 241259566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)